Chockalingam Shivashri, Wesley Hannah, M. Deepa, Saite Hemavathy, Duraivel Mohaneswari, Ghebremichael-Weldeselassie Yonas, R. Anjana, R. Uma, P. Saravanan
{"title":"Glycemic status of Asian Indian women during 3-5 years postpartum: Prospective follow-up of STRiDE cohort","authors":"Chockalingam Shivashri, Wesley Hannah, M. Deepa, Saite Hemavathy, Duraivel Mohaneswari, Ghebremichael-Weldeselassie Yonas, R. Anjana, R. Uma, P. Saravanan","doi":"10.21428/3d48c34a.27c55069","DOIUrl":null,"url":null,"abstract":"Background: South Asians have an increased predilection to gestational diabetes mellitus (GDM) and type 2 diabetes (T2D). This study reports on the postpartum glycaemic status in a well-established GDM cohort of Asian Indian women. Methods: The STratification of Risk of Diabetes in Early pregnancy (STRiDE) cohort included Asian Indian (n=2703) women who were screened for GDM using IADPSG criteria from early pregnancy (2016-2019). The STRiDE-Follow up study is an ongoing longitudinal study of STRiDE cohort, comprising of women diagnosed with and without GDM during index pregnancy. To date, 500 women (GDM-151, non-GDM-349), have been screened for glycaemic status and cardiovascular risk factors. The diagnosis of dysglycaemia (prediabetes and T2D) was by 2020 American Diabetes Association (ADA) criteria. Logistic regression model was used to estimate risk of prediabetes, T2D and combined dysglycaemia. Unadjusted and adjusted odds ratio (OR) (covariates: booking age, BMI, and waist circumference, family history of diabetes, socio-economic status (SES), and duration of follow-up) and 95% confidence interval (95%CI) were reported. Results: The mean duration of follow-up was 4.3 years post-delivery. The overall prevalence of prediabetes and T2D were 13.8% and 3.0% respectively. The prevalence of prediabetes and T2D among women with history of GDM were 27.8% and 8.6% respectively. The prevalence of dysglycaemia was significantly higher in the GDM compared to non-GDM women (36.4% vs. 8.3%, p<0.001). GDM women had higher odds of developing T2D (OR: 21.67; 95%CI: 4.8-97.7; p<0.001), prediabetes (OR","PeriodicalId":353726,"journal":{"name":"The Global Health Network Conference Proceedings 2022","volume":"1 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Global Health Network Conference Proceedings 2022","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21428/3d48c34a.27c55069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: South Asians have an increased predilection to gestational diabetes mellitus (GDM) and type 2 diabetes (T2D). This study reports on the postpartum glycaemic status in a well-established GDM cohort of Asian Indian women. Methods: The STratification of Risk of Diabetes in Early pregnancy (STRiDE) cohort included Asian Indian (n=2703) women who were screened for GDM using IADPSG criteria from early pregnancy (2016-2019). The STRiDE-Follow up study is an ongoing longitudinal study of STRiDE cohort, comprising of women diagnosed with and without GDM during index pregnancy. To date, 500 women (GDM-151, non-GDM-349), have been screened for glycaemic status and cardiovascular risk factors. The diagnosis of dysglycaemia (prediabetes and T2D) was by 2020 American Diabetes Association (ADA) criteria. Logistic regression model was used to estimate risk of prediabetes, T2D and combined dysglycaemia. Unadjusted and adjusted odds ratio (OR) (covariates: booking age, BMI, and waist circumference, family history of diabetes, socio-economic status (SES), and duration of follow-up) and 95% confidence interval (95%CI) were reported. Results: The mean duration of follow-up was 4.3 years post-delivery. The overall prevalence of prediabetes and T2D were 13.8% and 3.0% respectively. The prevalence of prediabetes and T2D among women with history of GDM were 27.8% and 8.6% respectively. The prevalence of dysglycaemia was significantly higher in the GDM compared to non-GDM women (36.4% vs. 8.3%, p<0.001). GDM women had higher odds of developing T2D (OR: 21.67; 95%CI: 4.8-97.7; p<0.001), prediabetes (OR